Science
Tool could improve success in translating drugs from animal studies to humans – Medical Xpress
About 50% of people who take the drug infliximab for inflammatory bowel diseases, such as Crohn’s disease, end up becoming resistant or unresponsive to it.
About 50% of people who take the drug infliximab for inflammatory bowel diseases, such as Crohn’s disease, end up becoming resistant or unresponsive to it.
Scientists might be able to catch problems like this one earlier in the drug development process, when drugs move from testing in animals to clinical trials, with a new computational model developed by researchers from Purdue University and Massachusetts Institute of Technology.
The researchers call the model “TransComp-R.” In a study publi…
-
General13 hours agoCampers evacuated, residents on alert as Moreton Island bushfire intensifies
-
Noosa News19 hours agoPerth Royal Show vendors upset by price hikes, say crowds are down in 2025
-
Business21 hours agoBell Potter names the best ASX shares to buy in October
-
General18 hours agoAustralia welcomes Gaza peace progress, hostage release